BioCentury
ARTICLE | Top Story

Protein Design Labs delays offering

February 8, 2000 8:00 AM UTC

PDLI delayed its proposed $100 million private placement of subordinated convertible notes in order to complete quality control testing of a new antibody lot for clinical studies. PDLI said that these additional quality tests were required to ensure sterility of the antibody. The company did not disclose which antibody required the additional tests. ...